Study Stopped
Technological problem
Combination of Neck Muscle Vibration and tDCS With Conventional Rehabilitation in Neglect Patients
HEMISTIM
Innovative Therapy Combining Neck Muscle Vibration and Transcranial Direct Current Stimulation in Association With Conventional Rehabilitation in Left Unilateral Spatial Neglect Patients: HEMISTIM Protocol
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
BACKGROUND: Unilateral spatial neglect (USN) rehabilitation remains a challenge and requires the development of new methods that can be easily integrated into conventional practice. The aim of the HEMISTIM protocol is to assess immediate and long-term functional outcomes and neuropsychological aspects of recovery, induced by an innovative association of left-side neck-muscle vibration (NMV) and anodal transcranial Direct Current Stimulation (tDCS) on the ipsilesional posterior parietal cortex during occupational therapy sessions in patients with left USN. METHODS: Participants will be randomly assigned to 4 groups: control, Left-NMV, Left-NMV + sham-tDCS or Left-NMV + anodal-tDCS. NMV will be applied during the first 15 minutes of occupational therapy and tDCS will be applied for 20 minutes, starting 5 minutes before, three days a week for three weeks. USN will be assessed at baseline, just at the end of the first experimental session, after the first and third weeks of the protocol and three weeks after its ending. DISCUSSION: Left NMV, by activating multisensory integration neuronal networks, might enhance beneficial effects obtained by conventional occupational therapy sessions since interesting post-effects were shown when it was combined with voluntary upper limb movements. The investigators expect to reinforce lasting intermodal recalibration through LTP-like plasticity induced by anodal tDCS. The HEMISTIM protocol represents a therapeutic innovation associated to conventional practice that could provide a partial solution to the rehabilitation challenges of the USN syndrome and some insights to its underlying mechanisms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2024
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2022
CompletedFirst Posted
Study publicly available on registry
March 16, 2022
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
February 7, 2024
February 1, 2024
3 years
February 21, 2022
February 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Catherine Bergego Scale
Functional scale assessing unilateral spatial neglect severity in daily life situations. This is a score on 30. The higher the score, the severe the unilateral spatial neglect
at the end of the first week of inclusion
Catherine Bergego Scale
Functional scale assessing unilateral spatial neglect severity in daily life situations. This is a score on 30. The higher the score, the severe the unilateral spatial neglect
Immediately following first session of occupational therapy.
Catherine Bergego Scale
Functional scale assessing unilateral spatial neglect severity in daily life situations. This is a score on 30. The higher the score, the severe the unilateral spatial neglect
after the first week of protocol
Catherine Bergego Scale
Functional scale assessing unilateral spatial neglect severity in daily life situations. This is a score on 30. The higher the score, the severe the unilateral spatial neglect
after the third week of protocol
Catherine Bergego Scale
Functional scale assessing unilateral spatial neglect severity in daily life situations. This is a score on 30. The higher the score, the severe the unilateral spatial neglect
3 weeks after the last session of intervention
Secondary Outcomes (25)
Fluff test
at the end of the first week of inclusion
Fluff test
Immediately following first session of occupational therapy.
Fluff test
after the first week of protocol
Fluff test
after the third week of protocol
Fluff test
3 weeks after the last session of intervention
- +20 more secondary outcomes
Study Arms (4)
Control patients
NO INTERVENTIONPatient receiving no additional treatment to conventional occupational therapy sessions
left-NMV
EXPERIMENTALPatient will be equipped with vibratory stimulators during conventional occupational therapy sessions. Only the left-side NMV vibrator will be activated.
left-NMV + sham-tDCS
SHAM COMPARATORPatient will be equipped with vibratory stimulators and with electrodes form sham-tDCS during conventional occupational therapy sessions. Only the left-side NMV vibrator will be activated.
left-NMV + anodal-tDCS
EXPERIMENTALPatient will be equipped with vibratory stimulators and with electrodes for tDCS during conventional occupational therapy sessions. Only the left-side NMV vibrator will be activated.
Interventions
Patient will receive neck muscle vibration during the first 15 minutes of occupational therapy. Vibratory stimulators will be fixed bilaterally on the skin over the belly of the trapezius muscles and fastened with straps. Only the left vibrator will be activated.
Patient will receive neck muscle vibration during the first 15 minutes of occupational therapy.. Vibratory stimulators will be fixed bilaterally on the skin over the belly of the trapezius muscles and fastened with straps. Only the left vibrator will be activated. Moreover, tDCS will be applied using an electrical stimulator (DC-STIMULATOR®, NeuroCare, Illmenau, Germany) through large saline-soaked sponge surface electrodes placed as follows: anode over the right (ipsilesional) posterior parietal cortex (P4 according to the International 10-20 EEG electrode placement system) and cathode over the left supraorbital region. The tDCS will be automatically turned off after 20 seconds. This allows the reproduction of the initial mild itching sensation at the beginning of active tDCS, thus ensuring that the patient stays blind to the activation status of the device.
Patient will receive neck muscle vibration during the first 15 minutes of occupational therapy. Vibratory stimulators will be fixed bilaterally on the skin over the belly of the trapezius muscles and fastened with straps. Only the left vibrator will be activated. Moreover, tDCS will be applied using an electrical stimulator (DC-STIMULATOR®, NeuroCare, Illmenau, Germany) through large saline-soaked sponge surface electrodes placed as follows: anode over the right (ipsilesional) posterior parietal cortex (P4 according to the International 10-20 EEG electrode placement system) and cathode over the left supraorbital region. A continuous 2 mA current will be delivered for 20 minutes simultaneously to NMV stimulation. The stimulation will begin 5 minutes before the beginning of occupational therapy.
Eligibility Criteria
You may qualify if:
- admitted in a post-stroke rehabilitation unit in the sub-acute phase (15 days to 6 months from the onset of stroke symptoms)
- at least 18 years old
- a first unilateral right hemispheric stroke
- diagnosis of stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI)
- Behavioral Inattention Test (c-BIT), inferior or equal to 129
You may not qualify if:
- unable to give informed consent
- pregnant women
- patients with skin lesions on the areas for electrode placement
- having history of metal-in-cranial injury
- epilepsy
- vestibulo-cochlear illness
- cardiac pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Estlead
- Université de Lorraine, DevAH (EA3450), Nancy, Francecollaborator
- Union de Gestion des Etablissements des Caisses d'Assurance Maladie - PACAcollaborator
- Institut Régional de Médecine Physique et de Réadaptation de Nancy - Etablissement de Lay Saint Christophecollaborator
Study Officials
- STUDY DIRECTOR
Hadrien Ceyte, PhD, HDR
Université de Lorraine, DevAH (EA3450), Nancy, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2022
First Posted
March 16, 2022
Study Start
October 1, 2024
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
May 1, 2028
Last Updated
February 7, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share